SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (304)5/8/2000 8:09:00 PM
From: allen menglin chen  Read Replies (1) | Respond to of 746
 
What are the "pure" proteomics plays? Don't tell me CRA and CRA only :)

But DoubleTwist claims CRA is their competitor, and I think CRA wants to hunt the genes after the gemone map is done. How can DT charge $650,000 if they haven't done some serious works? I hates DT now :)
Per DT
"It will be available at the end of the month, Tsinoremas said in a telephone interview. "

Everyone is putting May as their deadline.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News